Yesterday, Olaplex has made its first-ever acquisition in its 11-year history, acquiring Boston-based biotech start-up Purvala Bioscience for an undisclosed amount. The move underscores the bond repair leader’s commitment to advancing product innovation in the hair care category.
Founded in 2020 by Dr. Bradley Olsen, Professor of Chemical Engineering at MIT, Purvala develops bio-inspired technologies with applications across the health and beauty industries. Dr. Olsen’s research focuses on designing molecules modeled on naturally occurring biological structures, aiming to push the boundaries of sustainable and effective formulations.
“Since the very beginning, Olaplex was founded on the concept of innovation, with its original groundbreaking technology designed to empower stylists and their clients to achieve transformative results,” said Amanda Baldwin, CEO of Olaplex. “Scientific breakthroughs are what continue to inspire us as we remain committed to delivering the best possible products for our stylist community and our consumers. We believe that with Purvala Bioscience we have the potential to create the next generation of disruptive science-backed product innovation alongside our patent-protected bond-building technology, Bis-amino.”
According to Olaplex’s latest financial report, the company’s net sales in the second quarter rose 2.3% year-over-year to $106.3 million. Net income, however, swung from profit to loss — from a net profit of $5.8 million in the same period of 2024 to a net loss of $7.7 million in the same period of 2025, representing a year-over-year plunge of 234%.
